[Methoxy polyethylene glycol epoetin beta].
Taéron
Corinne
C
corinne.taeron@gmail.com
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D000075202:Contraindications; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications*; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins
D011994:Recombinant Proteins; C508420:continuous erythropoietin receptor activator; D004921:Erythropoietin; D011092:Polyethylene Glycols